Am. Martelli et al., Enhanced nuclear diacylglycerol kinase activity in response to a mitogenicstimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I, CANCER RES, 60(4), 2000, pp. 815-821
Results from several laboratories have established the existence in the nuc
leus of an autonomous polyphosphoinositide cycle, which is involved in both
cell proliferation and differentiation. A key step of intranuclear polypho
sphoinositide metabolism is the phospholipase C-mediated generation of diac
ylglycerol (DAG), In insulin-like growth factor (IGF)-I-stimulated Swiss 3T
3 cells, a transient elevation of intranuclear DAG levels is essential for
attracting the cw isoform of protein kinase C (PKC) to the nucleus. Previou
s evidence has shown that the nucleus also contains DAG kinase, ie., the en
zyme that yields phosphatidic acid from DAG, thus terminating PKC-mediated
signaling events. Here we show that IGF-I treatment of quiescent Swiss 3T3
cells results in the stimulation of nuclear DAG kinase activity. Time cours
e analysis showed an inverse relationship between nuclear DAG mass and DAG
kinase activity Levels. After IGF-I treatment, maximal enhancement of DAG k
inase activity was measured in the internal matrix domain of the nucleus. P
KC-alpha remained within the nuclear compartment, even when nuclear DAG mas
s returned to basal levels. This was conceivably due to interactions with s
pecific nuclear PKC-binding proteins, some of which were identified as lami
ns A, B, and C and protein C23/nucleolin. Treatment of cells with two DAG k
inase inhibitors, R59022 and R59949, blocked the IGF-I-dependent rise in nu
clear DAG kinase activity and maintained elevated intranuclear levels of DA
G, The two inhibitors also markedly potentiated the mitogenic effect of IGF
-I, These results suggest that nuclear DAG kinase plays a key role in regul
ating the levels of DAG present in the nucleus and that DAG is a key molecu
le for the mitogenic effect that IGF-I exerts on Swiss 3T3 cells.